Argenx SE ARGX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Net income | $1.3B | +55% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Research & development | $1.4B | +39% | FY ending Dec 31, 2025 |
Insider trades
No insider trades reported in the last 12 months.
Trades by members of Congress
1 member reported 3 buys and 0 sales since Oct 14, 2026. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Oct 27, 2026 | Nov 10, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Oct 15, 2026 | Nov 10, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $15K–$50K | Oct 14, 2026 | Nov 10, 2026 | Self |
Latest SEC filings
- News filing (foreign) 6-K · Nov 9, 2026
- News filing (foreign) 6-K · Nov 9, 2026
- News filing (foreign) 6-K · Oct 22, 2026
- News filing (foreign) 6-K · Oct 19, 2026
- News filing (foreign) 6-K · Oct 8, 2026
- News filing (foreign) 6-K · Sep 29, 2026
- News filing (foreign) 6-K · Aug 27, 2026
- News filing (foreign) 6-K · Aug 17, 2026
- News filing (foreign) 6-K · Aug 3, 2026
- News filing (foreign) 6-K · Jul 27, 2026
- News filing (foreign) 6-K · Jul 23, 2026
- News filing (foreign) 6-K · Jun 23, 2026
- News filing (foreign) 6-K · Jun 3, 2026
- News filing (foreign) 6-K · May 11, 2026
- News filing (foreign) 6-K · May 7, 2026
- News filing (foreign) 6-K · May 6, 2026
- News filing (foreign) 6-K · Apr 20, 2026
- News filing (foreign) 6-K · Mar 20, 2026
- Annual report (foreign) 20-F · Mar 19, 2026
- News filing (foreign) 6-K · Mar 19, 2026
- News filing (foreign) 6-K · Mar 6, 2026
- News filing (foreign) 6-K · Feb 26, 2026
- News filing (foreign) 6-K · Feb 26, 2026
- News filing (foreign) 6-K · Jan 13, 2026
- News filing (foreign) 6-K · Jan 12, 2026
About Argenx SE
Business description
- Industry
- Biological Products, (No Diagnostic Substances)
- Sector
- Life Sciences
- Headquarters
- Zwijnaarde
- Incorporated in
- Netherlands
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- Formerly
- argenx N.V
- SEC company number (CIK)
- 1697862
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.